470 related articles for article (PubMed ID: 30543145)
1. Non-interventional cardiologists' perspectives on the role of pharmacogenomic testing in cardiovascular medicine.
Deininger KM; Page RL; Lee YM; Kauffman YS; Johnson SG; Oreschak K; Aquilante CL
Per Med; 2019 Mar; 16(2):123-132. PubMed ID: 30543145
[TBL] [Abstract][Full Text] [Related]
2. Interventional cardiologists' attitudes towards pharmacogenetic testing and impact on antiplatelet prescribing decisions.
Hoffecker G; Kanter GP; Xu Y; Matthai W; Kolansky DM; Giri J; Tuteja S
Per Med; 2022 Jan; 19(1):41-49. PubMed ID: 34881641
[TBL] [Abstract][Full Text] [Related]
3. Primary care physician experiences with integrated pharmacogenomic testing in a community health system.
Lemke AA; Hutten Selkirk CG; Glaser NS; Sereika AW; Wake DT; Hulick PJ; Dunnenberger HM
Per Med; 2017 Sep; 14(5):389-400. PubMed ID: 29754567
[TBL] [Abstract][Full Text] [Related]
4. Stakeholder perspectives of the clinical utility of pharmacogenomic testing in solid organ transplantation.
Deininger KM; Tran JN; Tsunoda SM; Young GK; Lee YM; Anderson HD; Page Ii RL; Hirsch JD; Aquilante CL
Pharmacogenomics; 2019 Dec; 20(18):1291-1302. PubMed ID: 31755847
[No Abstract] [Full Text] [Related]
5. Providers' perspectives on the clinical utility of pharmacogenomic testing in pediatric patients.
Liko I; Lee YM; Stutzman DL; Blackmer AB; Deininger KM; Reynolds AM; Aquilante CL
Pharmacogenomics; 2021 Apr; 22(5):263-274. PubMed ID: 33657875
[No Abstract] [Full Text] [Related]
6. Patients' perspectives of a pharmacist-provided clinical pharmacogenomics service.
Martin JL; Lee YM; Corbin LW; Colson R; Aquilante CL
Pharmacogenomics; 2022 Jun; 23(8):463-474. PubMed ID: 35469451
[No Abstract] [Full Text] [Related]
7. Assessment of primary care practitioners' attitudes and interest in pharmacogenomic testing.
Smith DM; Namvar T; Brown RP; Springfield TB; Peshkin BN; Walsh RJ; Welsh JC; Levin B; Brandt N; Swain SM
Pharmacogenomics; 2020 Oct; 21(15):1085-1094. PubMed ID: 32969759
[No Abstract] [Full Text] [Related]
8. Results of a nationwide survey of Japanese pharmacists regarding the application of pharmacogenomic testing in precision medicine.
Tsuji D; Saito Y; Mushiroda T; Miura M; Hira D; Terada T
J Clin Pharm Ther; 2021 Jun; 46(3):649-657. PubMed ID: 33555613
[TBL] [Abstract][Full Text] [Related]
9. Pharmacogenetics in the clinical analysis laboratory: clinical practice, research, and drug development pipeline.
Miscio G; Paroni G; Bisceglia P; Gravina C; Urbano M; Lozupone M; Piccininni C; Prisciandaro M; Ciavarella G; Daniele A; Bellomo A; Panza F; Di Mauro L; Greco A; Seripa D
Expert Opin Drug Metab Toxicol; 2019 Sep; 15(9):751-765. PubMed ID: 31512953
[No Abstract] [Full Text] [Related]
10. The Ubiquitous Pharmacogenomics consortium: making effective treatment optimization accessible to every European citizen.
Manson LE; van der Wouden CH; Swen JJ; Guchelaar HJ
Pharmacogenomics; 2017 Jul; 18(11):1041-1045. PubMed ID: 28685652
[No Abstract] [Full Text] [Related]
11. Attitudes about pharmacogenomic testing vary by healthcare specialty.
Preys CL; Blout Zawatsky CL; Massmann A; Heukelom JV; Green RC; Hajek C; Hickingbotham MR; Zoltick ES; Schultz A; Christensen KD
Pharmacogenomics; 2023 Jul; 24(10):539-549. PubMed ID: 37458095
[No Abstract] [Full Text] [Related]
12. Veterans Affairs Pharmacogenomic Testing for Veterans (PHASER) clinical program.
Dong OM; Bates J; Chanfreau-Coffinier C; Naglich M; Kelley MJ; Meyer LJ; Icardi M; Vassy JL; Sriram P; Heise CW; Rivas S; Ribeiro M; Jacobitz R; Rozelle S; Chapman JG; Voora D
Pharmacogenomics; 2021 Feb; 22(3):137-144. PubMed ID: 33403869
[TBL] [Abstract][Full Text] [Related]
13. Pharmacogenetic testing in primary care practice: opinions of physicians, pharmacists and patients.
Frigon MP; Blackburn MÈ; Dubois-Bouchard C; Gagnon AL; Tardif S; Tremblay K
Pharmacogenomics; 2019 Jun; 20(8):589-598. PubMed ID: 31190623
[No Abstract] [Full Text] [Related]
14. Pharmacogenomic and pharmacogenetic-guided therapy as a tool in precision medicine: current state and factors impacting acceptance by stakeholders.
Hess GP; Fonseca E; Scott R; Fagerness J
Genet Res (Camb); 2015 Jun; 97():e13. PubMed ID: 26030725
[TBL] [Abstract][Full Text] [Related]
15. QPGx-CARES: Qatar pharmacogenetics clinical applications and research enhancement strategies.
Abdel-Latif R; Badji R; Mohammed S; Al-Muftah W; Mbarek H; Darwish D; Assaf D; Al-Badriyeh D; Elewa H; Afifi N; Masoodi NA; Omar AS; Al Suwaidi J; Bujassoum S; Al Hail M; Ismail SI; Althani A
Clin Transl Sci; 2024 Jun; 17(6):e13800. PubMed ID: 38818903
[TBL] [Abstract][Full Text] [Related]
16. North Carolina cardiologists' knowledge, opinions and practice behaviors regarding the relationship between periodontal disease and cardiovascular disease.
Mosley M; Offenbacher S; Phillips C; Granger C; Wilder RS
J Dent Hyg; 2014 Oct; 88(5):275-84. PubMed ID: 25325723
[TBL] [Abstract][Full Text] [Related]
17. A nationwide cross-sectional survey of pharmacy students on pharmacogenetic testing in The Netherlands.
Bank PC; Swen JJ; Guchelaar HJ
Pharmacogenomics; 2018 Mar; 19(4):311-319. PubMed ID: 29473451
[TBL] [Abstract][Full Text] [Related]
18. National survey of physicians' perspectives on pharmacogenetic testing in solid organ transplantation.
Deininger KM; Tsunoda SM; Hirsch JD; Anderson H; Lee YM; McIlvennan CK; Page RL; Tran JN; Aquilante CL
Clin Transplant; 2020 Oct; 34(10):e14037. PubMed ID: 32654213
[TBL] [Abstract][Full Text] [Related]
19. Characterizing Pharmacogenomic-Guided Medication Use With a Clinical Data Repository.
Mathias PC; Hendrix N; Wang WJ; Keyloun K; Khelifi M; Tarczy-Hornoch P; Devine B
Clin Pharmacol Ther; 2017 Aug; 102(2):340-348. PubMed ID: 28073152
[TBL] [Abstract][Full Text] [Related]
20. Assessing feasibility of delivering pharmacogenetic testing in a community pharmacy setting.
Haga SB; Moaddeb J; Mills R; Voora D
Pharmacogenomics; 2017 Mar; 18(4):327-335. PubMed ID: 28244804
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
